Business
Exercise period extension - existing share options
Exercise period extension - existing share options.
About this update from Oxford Biodynamics Plc
[{"type":"text","content":"\n \n \n \n Oxford BioDynamics Plc\n \n \n \n \n (\n \n \"OBD\" or the \"Company\" and, together with its subsidiaries, the \"Group\")\n \n \n \n \n \n \n \n \n Exercise period extension of existing Share Options\n \n \n \n \n \n \n 14 December 2022 -\n Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests for immune health based on the EpiSwitch® 3D genomics platform, announces an amendment to the exercise period for certain options over ordinary shares granted under its 2008 Share Option Scheme (\"2008 Plan\").\n \n As disclosed in the Company's AIM Admission Document dated 1 December 2016 (Part 7, paragraph 10.3) (\"Admission Document\"), non-EMI share options (\"Non-EMI Options\") were granted to, amongst others, certain founders of the Company, including Dr Alexandre Akoulitchev (Chief Scientific Officer, PDMR and a Director) as shown in the following table:\n \n \n \n \n \n \n Option holder\n \n \n \n \n Date of Grant\n \n \n \n \n Non-EMI Options\n \n \n \n \n Exercise Price (pence)\n \n \n \n \n \n Alexandre Akoulitchev\n \n \n 16 July 2008\n \n \n 1,096,131\n \n \n 34.0\n \n \n \n \n \n The independent directors of the Company have approved an extension of the exercise period of the Non-EMI Options held by Dr Akoulitchev. The Non-EMI Options were due to expire on 31 December 2022 unless exercised prior to that date but will now expire on 31 December 2027. All other terms and conditions relating to the Non-EMI Options, including the exercise price, remain unchanged. Dr Akoulitchev holds ordinary shares and share options as follows:\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Total number of options over Ordinary Shares\n \n \n \n \n \n \n Ordinary Shares held\n \n \n \n \n \n \n \n \n Number\n \n \n \n \n \n \n % of current issued share capital\n \n \n \n \n \n \n \n Dr Alexandre Akoulitchev\n \n \n \n \n 1,346,131\n \n \n \n \n 6,303,082\n \n \n \n \n 4.30%\n \n \n \n \n \n \n The change to the expiry date of the Non-EMI Options is notifiable pursuant to UK Market Abuse Regulation. The notification below, made in accordance with the requirements of UK Market Abuse Regulation, provides further details:\n \n \n \n \n \n \n 1\n \n \n \n \n Details of the person discharging managerial responsibilities/person closely associa...